Status:

COMPLETED

Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type I Diabetes

Eligibility:

All Genders

18+ years

Brief Summary

This study will test dihydrotetrabenazine, or 11C-DTBZ, a radioactive tracer, as an imaging agent in positron emission tomography (PET). That tracer may have the ability to noninvasively measure beta ...

Detailed Description

Diabetes is a metabolic disorder in which pancreatic insulin producing B-cells (located in cell clusters called the islets of Langerhans) no longer produce sufficient insulin to maintain an individual...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • Patients with T1DM inclusion criteria:
  • Age greater than 18
  • History consistent with T1DM
  • non-obese (BMI less than 35 kg/m(2)), and
  • normal insulin sensitivity (as judged by insulin requirements less than or equal to 0.8 unit/kg/day).
  • Low C-Peptide (less than or equal to 0.6 ng/ml)
  • Pancreas Transplant Patient inclusion criteria:
  • Age greater than 18
  • History consistent with T1DM (as above) PRIOR to pancreas transplant.
  • Normal pancreas allograft function for at least the preceding 1 year.
  • No acute rejection episodes within the past year.
  • Control Patient inclusion criteria:
  • Age greater than 18
  • No history of diabetes.
  • Fasting blood glucose less than 100 mg/dl.
  • Normal oral glucose tolerance.
  • BMI less than 35 kg/m(2)
  • Exclusion criteria for all:
  • Liver dysfunction as determined by history, physical examination, and standard liver function testing (abnormal values for AST, ALT, Total/Direct Bilirubin, Alkaline Phosphatase)
  • Coagulopathy
  • Pregnancy
  • Current breast feeding
  • Use of MAO inhibitors or Levodopa
  • Patients with a contraindication to MRI scanning.

Exclusion

    Key Trial Info

    Start Date :

    July 9 2006

    Trial Type :

    OBSERVATIONAL

    End Date :

    February 6 2008

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT00351650

    Start Date

    July 9 2006

    End Date

    February 6 2008

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892